Truist Financial’s Ascendis Pharma A/S ASND Stock Holding History

Truist Financial’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$424K	Buy	1,591 +327	+26%	+$76.4K	﹤0.01%	2312
2026 Q1	$289K	Sell	1,264 -525	-29%	-$118K	﹤0.01%	2412
2025 Q4	$381K	Buy	1,789 +494	+38%	+$102K	﹤0.01%	2191
2025 Q3	$257K	Buy	+1,295	New	+$242K	﹤0.01%	2406
2020 Q3	–	Sell	-5	Closed	-$1K	–	2442
2020 Q2	$1K	Buy	+5	New	+$686	﹤0.01%	2400

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Truist Financial's ASND Position: Q2 2026 in Review

Truist Financial increased its Ascendis Pharma A/S (ASND) stake by 26% in Q2 2026, buying an estimated $76.4K and bringing the position to 1,591 shares worth $424K. The position accounts for ﹤0.01% of the portfolio, ranked #2312.

Truist Financial first reported a position in ASND in Q2 2020 and has held it in 5 quarters since. 313 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Truist Financial held 1,591 shares of Ascendis Pharma A/S worth $424K as of Q2 2026.
Truist Financial bought 327 Ascendis Pharma A/S shares in Q2 2026, an estimated $76.4K.
Ascendis Pharma A/S made up ﹤0.01% of Truist Financial's portfolio in Q2 2026, its #2312 holding.
Truist Financial first reported a position in Ascendis Pharma A/S in Q2 2020 and has held it in 5 quarters since.
313 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.